{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["6"],"submitter":["Fujita J"],"pubmed_abstract":["<h4>Background</h4>The mental health of children and adolescents is a growing public health concern, with increasing rates of depression and anxiety impacting their emotional, social, and academic well-being. In Japan, access to timely psychiatric care is limited, leading to extended waiting periods that can range from 3 months to a year. Artificial intelligence (AI)-driven chatbots, such as emol (Emol Inc) that integrates acceptance and commitment therapy, show potential as digital solutions to support young patients during these waiting times. The AI chatbot emol was selected based on a comprehensive review of Japanese mental health technology apps, including in-person evaluations with company representatives.<h4>Objective</h4>This exploratory parallel-group randomized controlled trial e"],"journal":["JMIRx med"],"pagination":["e70960"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12413189"],"repository":["biostudies-literature"],"pubmed_title":["Challenges in Implementing a Mobile AI Chatbot Intervention for Depression Among Youth on Psychiatric Waiting Lists: Randomized Controlled Study Termination Report."],"pmcid":["PMC12413189"],"pubmed_authors":["Suda A","Ishii M","Miyazaki T","Takayama M","Sho N","Yamaguchi H","Yano Y","Shinoda S","Otsuki M","Moroga T","Fujita J"],"additional_accession":[]},"is_claimable":false,"name":"Challenges in Implementing a Mobile AI Chatbot Intervention for Depression Among Youth on Psychiatric Waiting Lists: Randomized Controlled Study Termination Report.","description":"<h4>Background</h4>The mental health of children and adolescents is a growing public health concern, with increasing rates of depression and anxiety impacting their emotional, social, and academic well-being. In Japan, access to timely psychiatric care is limited, leading to extended waiting periods that can range from 3 months to a year. Artificial intelligence (AI)-driven chatbots, such as emol (Emol Inc) that integrates acceptance and commitment therapy, show potential as digital solutions to support young patients during these waiting times. The AI chatbot emol was selected based on a comprehensive review of Japanese mental health technology apps, including in-person evaluations with company representatives.<h4>Objective</h4>This exploratory parallel-group randomized controlled trial e","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Sep","modification":"2026-06-04T06:54:13.086Z","creation":"2026-05-06T03:12:14.305Z"},"accession":"S-EPMC12413189","cross_references":{"pubmed":["41055096"],"doi":["10.2196/70960"]}}